Literature DB >> 21570202

Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.

Daniel R Gomez1, Cherry L Estilo, Suzanne L Wolden, Michael J Zelefsky, Dennis H Kraus, Richard J Wong, Ashok R Shaha, Jatin P Shah, James G Mechalakos, Nancy Y Lee.   

Abstract

PURPOSE: Osteoradionecrosis (ORN) is a known complication of radiation therapy to the head and neck. However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated. METHODS AND MATERIALS: From December 2000 to July 2007, 168 patients from our institution have been previously reported for IMRT of the oral cavity, nasopharynx, larynx/hypopharynx, sinus, and oropharynx. All patients underwent pretreatment dental evaluation, including panoramic radiographs, an aggressive fluoride regimen, and a mouthguard when indicated. The median maximum mandibular dose was 6,798 cGy, and the median mean mandibular dose was 3,845 cGy. Patient visits were retrospectively reviewed for the incidence of ORN, and dental records were reviewed for the development of dental events. Univariate analysis was then used to assess the effect of mandibular and parotid gland dosimetric parameters on dental endpoints.
RESULTS: With a median clinic follow-up of 37.4 months (range, 0.8-89.6 months), 2 patients, both with oral cavity primaries, experienced ORN. Neither patient had preradiation dental extractions. The maximum mandibular dose and mean mandibular dose of the 2 patients were 7,183 and 6,828 cGy and 5812 and 5335 cGy, respectively. In all, 17% of the patients (n = 29) experienced a dental event. A mean parotid dose of >26 Gy was predictive of a subsequent dental caries, whereas a maximum mandibular dose >70 Gy and a mean mandibular dose >40 Gy were correlated with dental extractions after IMRT.
CONCLUSIONS: ORN is rare after head-and-neck IMRT, but is more common with oral cavity primaries. Our results suggest different mechanisms for radiation-induced caries versus extractions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21570202     DOI: 10.1016/j.ijrobp.2011.02.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  38 in total

1.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

2.  Case control study to assess the possibility of decrease the risk of osteoradionecrosis in relation to the dose of radiation absorbed by the jaw.

Authors:  Fabrizio Carini; Concetta Bucalo; Vito Saggese; Dario Monai; Gianluca Porcaro
Journal:  Ann Stomatol (Roma)       Date:  2012-11-14

3.  The influence of parotid gland sparing on radiation damages of dental hard tissues.

Authors:  Jeremias Hey; Johannes Seidel; Ramona Schweyen; Yvonne Paelecke-Habermann; Dirk Vordermark; Christian Gernhardt; Thomas Kuhnt
Journal:  Clin Oral Investig       Date:  2012-10-05       Impact factor: 3.573

4.  Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study.

Authors:  Pei-Hsun Liao; Chi-Hsiang Chu; Yao-Min Hung; Pei-Ling Tang; Tsu-Jen Kuo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

5.  Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor.

Authors:  Adepitan A Owosho; SaeHee K Yom; Zhiqiang Han; Kevin Sine; Nancy Y Lee; Joseph M Huryn; Cherry L Estilo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-07-19

Review 6.  Oral rehabilitation of the cancer patient: A formidable challenge.

Authors:  Ivana Petrovic; Evan B Rosen; Evan Matros; Joseph M Huryn; Jatin P Shah
Journal:  J Surg Oncol       Date:  2018-05-03       Impact factor: 3.454

7.  Osteoradionecrosis in patients with salivary gland malignancies.

Authors:  J Rhet Tucker; Li Xu; Erich M Sturgis; Abdallah S R Mohamed; Theresa M Hofstede; Mark S Chambers; Stephen Y Lai; Clifton David Fuller; Beth Beadle; G Brandon Gunn; Katherine A Hutcheson
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

8.  Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.

Authors:  Kanako Takayama; Tatsuya Nakamura; Akinori Takada; Chiyoko Makita; Motohisa Suzuki; Yusuke Azami; Takahiro Kato; Yuichiro Hayashi; Takashi Ono; Yutaka Toyomasu; Masato Hareyama; Yasuhiro Kikuchi; Takashi Daimon; Kenji Mitsudo; Iwai Tohnai; Nobukazu Fuwa
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-31       Impact factor: 4.553

9.  Radiographic osteoradionecrosis of the jaw with intact mucosa: Proposal of clinical guidelines for early identification of this condition.

Authors:  Adepitan A Owosho; Arvin Kadempour; SaeHee K Yom; Joseph Randazzo; C Jillian Tsai; Nancy Y Lee; Ashok R Shaha; Joseph M Huryn; Cherry L Estilo
Journal:  Oral Oncol       Date:  2015-10-09       Impact factor: 5.337

10.  Radiotherapy does not impair dentin adhesive properties in head and neck cancer patients.

Authors:  Roberta Galetti; Alan Roger Santos-Silva; Alberto Nogueira da Gama Antunes; Fabio de Abreu Alves; Marcio Ajudarte Lopes; Mario Fernando de Goes
Journal:  Clin Oral Investig       Date:  2013-12-06       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.